More than half of the country's top 100 drug companies have kickbacks, how to effectively solve the problem?

The top 100 pharmaceutical companies have the problem of kickbacks, in fact, this is a common phenomenon in the pharmaceutical enterprises, and can even be said to be the unspoken rules, and want to put an end to this situation will have to start from the interests, and also to implement an effective monitoring system, so that some of the blacklisted pharmaceutical enterprises in their original form.

Pharmaceutical companies generally have the problem of eating kickbacks, and even the top 100 pharmaceutical companies are no exception. And this kickback problem in that industry, and even become a common phenomenon. This is also because the enterprise has been operating for too long, some internal corruption phenomenon, those who are not willing to make improvements, but instead of playing the idea of money. This is because there are always some unmotivated employees in the organization, thus also harming the interests of the company, not willing to contribute to the company and the problem of kickbacks is also caused by these people. This is the so-called enterprise moths, only after these moths to pull out, can make the enterprise better.

In fact, not only these top 100 pharmaceutical companies within the existence of business assholes, it should be said that the development of society to the present day in various places are the existence of the so-called assholes. And in the face of these so-called assholes, should also be to address the root cause. Many bosses are also aware of this situation, but forced to have no way to solve the problem, but also can only let those people free. To solve this problem, first of all, the government will have to issue certain rules and regulations to market supervision, with the law to let those people existing.

And the drug companies also need to carry out self-reform, never let a person dominate, must be implemented in the supervision in place. And for some important positions must be integrity control and attention, in the procurement time must be more careful. The company can also engage in a credibility assessment within the enterprise, in accordance with the credibility to determine the assessment of an employee's performance. And also to some pharmaceutical companies to set up a blacklist, so that some of the industry moths have nowhere to hide, market supervision should also be implemented.